biofilm formation – Page 2

Antifungal Effects of Pterostilbene on Candida albicans, Candida dubliniensis, and Microcosm Biofilms of Denture Stomatitis

mycolabadmin

Pterostilbene, a natural compound found in blueberries and grapes, has been shown to effectively kill Candida fungi that cause denture-related mouth infections. In laboratory tests, it successfully eliminated fungal cells and disrupted harmful biofilms within 8 hours. When tested in a living organism model, pterostilbene proved safe and reduced infection severity, suggesting it could be a promising natural alternative to conventional antifungal medications.

Editorial: Fungal virulence

mycolabadmin

Fungal infections are becoming more dangerous and common worldwide, especially as climate change warms the planet. Scientists are studying how fungi develop the ability to cause disease, focusing on features like their stickiness to human tissues and ability to form protective biofilms. Recent research shows that specific proteins and growth conditions affect how dangerous different fungi are and how our immune system responds to them. Understanding these mechanisms could help doctors develop better treatments and vaccines against fungal infections.

Do farnesol and tyrosol production in Candidozyma auris biofilms reflect virulence potential?

mycolabadmin

Researchers discovered that a dangerous fungus called Candidozyma auris produces signaling molecules called farnesol and tyrosol in biofilms. These molecules appear to be linked to how dangerous the fungus is—strains that produce more of these molecules were more virulent in infection studies. Understanding these signaling molecules could help develop new strategies to fight this drug-resistant pathogen.

Functional Amyloids in Adhesion of Non-albicans Candida Species

mycolabadmin

Candida fungi cause common infections and form tough biofilms that resist treatment. These fungi stick to body surfaces using proteins called adhesins that form amyloid-like structures. Researchers found that special peptides can block these amyloid structures in several Candida species, preventing them from sticking to cells and potentially offering a new way to fight these infections.

Progress of Antimicrobial Mechanisms of Stilbenoids

mycolabadmin

Stilbenoids are natural compounds found in plants that can fight harmful bacteria and fungi in multiple ways. Unlike traditional antibiotics that only kill microbes, stilbenoids can also prevent infections by disrupting biofilm formation and weakening pathogen virulence. These compounds show promise in combating drug-resistant infections without promoting further resistance development, making them valuable candidates for new antibiotic medicines.

Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature

mycolabadmin

Candida krusei is a dangerous fungus that can cause fluid buildup around the lungs (empyema), particularly in transplant patients. Unlike common fungal infections that respond to fluconazole, this species is naturally resistant to this drug, making it harder to treat. The fungus forms protective biofilms that shield it from treatment, requiring combination antifungal medications and sometimes surgery to drain the fluid and remove infected tissue for successful recovery.

Genomic Insights of Candida krusei, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance

mycolabadmin

Candida krusei is a yeast that causes serious bloodstream infections, particularly in people with weakened immune systems. Unlike many other fungi, it naturally resists common antifungal drugs like fluconazole, making infections hard to treat. The organism can form protective biofilms and has multiple genetic mechanisms that help it survive antifungal treatment. Researchers are exploring new drugs and treatment strategies to combat this growing health threat, especially in hospitals.

Clinical profiling, antifungal drug susceptibility, and biofilm formation ability in pulmonary mucormycosis

mycolabadmin

This study examined 26 patients with a serious lung fungal infection called mucormycosis in a Beijing hospital. Most patients were older with health problems like diabetes and high blood pressure, and sadly about 4 in 10 died. Interestingly, most patients had other infections (viral or fungal) before developing mucormycosis. The researchers tested which antifungal drugs worked best against the fungus, finding that amphotericin B was most effective, though it can damage kidneys. They also discovered that most of the fungal strains could form protective biofilm structures, making treatment more difficult.

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

Researchers studied why some fungal nail infections caused by Candida albicans stop responding to the antifungal drug itraconazole. They found that resistant fungal cells have higher activity of genes that pump the drug out of cells and produce slimy protective coatings called biofilms. These resistant fungi also formed less dense biofilms when the drug was present from the start. Understanding these resistance mechanisms could help develop new treatments by targeting the pump systems or breaking down the protective biofilm layers.

Submerged Fermentation of Rhizopus sp. for l-asparaginase Production in Lymphoma Therapy

mycolabadmin

Researchers developed a new way to produce an anti-cancer enzyme called L-asparaginase using a fungus called Rhizopus, which could offer a safer alternative to current bacterial sources. They designed and tested a special bioreactor system that allows the fungus to grow as a biofilm, significantly increasing enzyme production. The system achieved enzyme activity levels much higher than previous laboratory methods, suggesting it could be scaled up for industrial pharmaceutical production.

Research Topic: biofilm formation